论文部分内容阅读
目的:观察环孢菌素A(CsA)治疗儿童难治性贫血(MAS蛳RA)的疗效。方法:用CsA治疗MDS蛳RA6例,CsA 8 mg·kg-1·d-13 个月左右,病情基本缓解减量为5 mg·kg-1·d-1 ,继续用至0.5 a ~ 1 a改为2 mg·kg-1·d-1 小剂量维持。结果:治疗3 个月基本缓解3 例,6 个月基本缓解1例,12 个月基本缓解2例。结论:CsA治疗儿童难治性贫血有较好的预后及转归。
Objective: To observe the efficacy of cyclosporin A (CsA) in the treatment of children with refractory anemia (MAS 蛳 RA). Methods: 6 cases of MDS 蛳 RA were treated with CsA, 8 mg · kg-1 · d-13 for CsA for 8 months. The basic relief dose was 5 mg · kg-1 · d-1, To 2 mg · kg-1 · d-1 low-dose maintenance. Results: Three cases were basically relieved in 3 months, 1 case basically relieved in 6 months and 2 cases basically relieved in 12 months. Conclusion: CsA has a better prognosis and prognosis in children with refractory anemia.